Table 2

Median survival based on Eag and HERG immunoreactivity and other prognostic markers.

Median survival, Months(IQR)

P (log rank)


Eag staining


Low/Intermediate

24.1 (18.9-29.2)


High

13.8 (7.2-20.3)

0.016



HERG staining


Low/Intermediate

22.4 (14.1-30.6)


High

16.4 (9.7-23.0)

0.586



Stage


1

137.6 (48.8-226.3)


2

28.4 (4.8-51.9)


3

13.0 (9.0-16.9)


4

7.3 (0-15.2)

< 0.001



Grade


G1

28.9 (17.2-40.5)


G2

33.1 (16.4-49.7)


G3

16.0 (13.0-18.9)

0.001



Residual disease


No macroscopic disease (Optimal debulking)

65.2 (37.5-92.8)


Macroscopic disease

10.7 (7.6-13.7)

< 0.001



Histological type


Serous

17.3 (12.6-21.9)


Mucinous

30.7 (0-64.7)

< 0.001


Endometriod

26.6 (5.3-47.8)


Clear cell

155 (89.7-222)


Undifferentiated

13.3(5.3-21.2)



Adjuvant

Chemotherapy


Yes

20.3 (15.4-25.1)


No

18.8 (0.6-36.9)

0.04


Asher et al. Diagnostic Pathology 2010 5:78   doi:10.1186/1746-1596-5-78

Open Data